REACH Home

About Care Fertility and Reach/Clinical Research

Clinical Research

Explore More...

Reach Fertility has an experienced research division solely dedicated to conducting clinical research trials. Our research has been published in leading fertility journals and contributed to advancements in the field of Reproductive Endocrinology. Clinical research trial participants may qualify to receive low-cost or no-cost fertility treatment.  We currently have 2 research studies open for enrollment: The Rebalance Study, and The Fertilo IVF study. More information below:                                                                                                                                                                                                                                                        Fertilo IVF Study                                                                                                                                                                                                                                                                                                                                          Research Study for a New Approach to IVF. Learn More HERE                                                                                                                                                                                                                                                                     This clinical study is researching a new fertility option that may shorten the in vitro fertilization (IVF)
process by maturing oocytes (eggs) in the lab instead of the body. This may reduce the risk of Ovarian
Hyperstimulation Syndrome (OHSS) and shorten the overall treatment process.
The process of maturing eggs outside the body, called in vitro maturation (IVM), has been around for
more than 30 years. This study is evaluating an investigational IVM treatment that uses engineered
ovarian support cells to help mature eggs prior to embryo transfer.
The investigational product is being compared to an FDA-approved IVM product. If you’re having trouble
getting pregnant or planning to use assisted reproductive technology, you may be eligible to participate.   FILL OUT THE FORM BELOW IF YOU MEET THE FOLLOWING CRITERIA
• Are a woman aged 18-35
• Have a Body Mass Index (BMI) between 21-40
• Have been trying to conceive for 12+ months, or are using donor sperm
• Are planning to freeze embryos and transfer within 2 months     

  • The investigational REBALANCE Study is currently recruiting patients. Learn More about this PCOS study HERE

    Women diagnosed with PCOS-related infertility and meeting the REBALANCE Study’s entry criteria may be eligible. Key entry criteria are women who:
    • Are between 18 to 40 years old.
    • Are experiencing anovulatory infertility due to PCOS.
    • Have a BMI < 40.
    • Have had no clinical response to ovulation induction treatment such as letrozole or clomiphene citrate or are contraindicated for or decline such treatment.
    • Are currently seeking immediate fertility.

 Complete the info box below if you are interested in qualifying for either of these programs.

Please contact callcenter@northcarolinafertility.com 

 

Contact our team to get started at 704-343-4444Dr Crain

FOR MORE INFORMATION ABOUT ENROLLING IN A CLINICAL RESEARCH TRIAL, PLEASE SUBMIT THE FORM BELOW.

Contact Reach Fertility
Explore More...
Ready to Get Started?
Schedule your consultation with a specialist today.

Sart Resolve Bundle of Joy Aetna Optum
Livestrong Fertility Network Progyny Maven Clinic Univfy
Sart
Resolve
Bundle of Joy
Aetna
Optum
Livestrong Fertility Network
Progyny
Maven Clinic
Univfy